Incidental Mutation 'F5426:Sh2d1b1'
ID 588
Institutional Source Beutler Lab
Gene Symbol Sh2d1b1
Ensembl Gene ENSMUSG00000102418
Gene Name SH2 domain containing 1B1
Synonyms Eat2a, Eat2, Sh2d1b, EAT-2
Accession Numbers
Essential gene? Probably non essential (E-score: 0.061) question?
Stock # F5426 (G1) of strain 24G1
Quality Score
Status Validated
Chromosome 1
Chromosomal Location 170104889-170114338 bp(+) (GRCm39)
Type of Mutation splice site
DNA Base Change (assembly) C to A at 170107350 bp (GRCm39)
Zygosity Heterozygous
Amino Acid Change
Ref Sequence ENSEMBL: ENSMUSP00000137069 (fasta)
Gene Model predicted gene model for transcript(s): [ENSMUST00000179976]
AlphaFold no structure available at present
Predicted Effect probably null
Transcript: ENSMUST00000179976
SMART Domains Protein: ENSMUSP00000137069
Gene: ENSMUSG00000102418

DomainStartEndE-ValueType
SH2 3 92 1.05e-26 SMART
Meta Mutation Damage Score 0.9755 question?
Coding Region Coverage
  • 1x: 78.1%
  • 3x: 56.4%
Het Detection Efficiency 35.2%
Validation Efficiency 91% (29/32)
MGI Phenotype FUNCTION: [Summary is not available for the mouse gene. This summary is for the human ortholog.] By binding phosphotyrosines through its free SRC (MIM 190090) homology-2 (SH2) domain, EAT2 regulates signal transduction through receptors expressed on the surface of antigen-presenting cells (Morra et al., 2001 [PubMed 11689425]).[supplied by OMIM, Mar 2008]
PHENOTYPE: Mice homozygous for a knock-out allele exhibit NK cells with enhanced cytolytic capacity and an increased IFN-gamma secretion. Mice homozygous for a different knock-out allele exhibit impaired NK cell cytolysis. [provided by MGI curators]
Allele List at MGI

All alleles(4) : Targeted, knock-out(4)

Other mutations in this stock
Total: 10 list
GeneRefVarChr/LocMutationPredicted EffectZygosity
Cdk5rap2 A T 4: 70,173,040 (GRCm39) V1344E probably benign Het
D16Ertd472e C T 16: 78,344,889 (GRCm39) C73Y probably damaging Het
Grk4 G A 5: 34,902,503 (GRCm39) probably benign Het
Odc1 G A 12: 17,599,424 (GRCm39) probably null Het
Or5v1 A C 17: 37,810,427 (GRCm39) K295T probably damaging Het
Prss12 T C 3: 123,300,121 (GRCm39) V744A probably damaging Het
Pudp A T 18: 50,701,612 (GRCm39) N40K probably benign Het
Rab30 T C 7: 92,478,876 (GRCm39) I107T possibly damaging Het
Ryr3 T A 2: 112,596,683 (GRCm39) probably benign Het
Tmc5 T A 7: 118,222,546 (GRCm39) V82D probably benign Het
Other mutations in Sh2d1b1
AlleleSourceChrCoordTypePredicted EffectPPH Score
R0402:Sh2d1b1 UTSW 1 170,107,342 (GRCm39) splice site probably benign
R7958:Sh2d1b1 UTSW 1 170,110,704 (GRCm39) missense probably benign 0.21
R8359:Sh2d1b1 UTSW 1 170,110,693 (GRCm39) splice site probably null
Nature of Mutation

DNA sequencing using the SOLiD technique identified a C to A transversion at base pair 172209912 in the Genbank genomic region NC_000067 for the Sh2d1b1 gene on chromosome 1 (TCCCCAACAG ->TCCCCAAAAG). The mutation is located within intron 1 from the ATG exon, three nucleotides to the next exon. The Sh2d1b1 gene contains 4 total exons using Genbank record NM_012009.4 . The mutation has been confirmed by DNA sequencing using the Sanger method (Figure 1).

Protein Function and Prediction

The Sh2d1b1 gene encodes a 132 amino acid protein that plays a role in controlling signal transduction through at least four receptors, CD84, SLAMF1, LY9 and CD244, expressed on the surface of professional antigen-presenting cells.  The protein binds to phosphorylated receptors and contains an SH2 domain at residues 5-101 (Uniprot O35324). Mice homozygous for a knock-out allele exhibit natural killer (NK) cells with enhanced cytolytic capacity and an increased IFN-gamma secretion. Mice homozygous for a different knock-out allele exhibit impaired NK cell cytolysis.

Posted On 2011-03-08